agoniste du glp 1 GLP1 Receptor Agonists—Effects beyond Obesity and Diabetes glp-1_analogs [TUSOM | Pharmwiki]

However, patient satisfaction data indicate that once weekly injections result in higher patient satisfaction compared with twice daily injections [11]

Egypt J Anim Prod

In other words, the body does not appear to become resistant simply because therapy was paused

In the STEP 1 study, participants who were overweight or obese and were given 2.4 mg of Semaglutide once weekly injection in addition to lifestyle intervention had a sustained, clinically relevant reduction in body weight

Adding urgency to this conversation, BMJ meta-analysis found that GLP-1 treatment discontinuation typically occurs within the first year, and that weight regain after stopping can be more rapid than after dietary interventions alone